Financial PerformanceTotal sales were $630 million, representing a 116% year-over-year increase, and surpassed the Street's expectation of $615 million.
Operational SynergyGMED is confident in its integration efforts and expects to achieve $170 million in cost synergies with 40% in Year 1.
Product DevelopmentGMED continues to invest heavily in product development, having launched four products during Q2 2024, with expectations for record launches this year.